The Cineworld share price might be heading to zero

Cineworld publishes encouraging earnings, but its share price could still be heading to zero. Zaven Boyrazian explains what’s going on.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The Cineworld (LSE:CINE) share price has had a rough ride since the pandemic began. After being forced to close its doors in 2020, the group saw its revenue stream evaporate while the bills kept coming in. Today, the operating environment has drastically improved. Lockdown restrictions seem to be firmly in the rear-view mirror, and seats are once again being filled.

But as positive as things may seem on the surface, there is a brewing problem at the heart of this business. And I think it could be enough to trigger a bankruptcy. Let’s explore.

The positive 2021 results

Before delving into my concerns, I feel it’s important to stress that not everything is terrible. In fact, looking at the latest results, there are several reasons to be optimistic about the Cineworld share price.

Firstly, revenue is heading back in the right direction, with total sales for 2021 coming in at $1.8bn versus $852.3m a year ago. Obviously, seeing the top line more than double is an encouraging sight. And it’s enabled the revenue stream to recover to just over 40% of pre-pandemic levels.

Meanwhile, the bottom line has also seen some drastic improvement. Cineworld remains unprofitable. But its after-tax losses came in at $565.8m versus $2.65bn in 2020. Most of this improvement can be attributed to a 75.2% jump in admissions, clearly demonstrating pent-up demand from moviegoers. However, it’s worth noting management also benefited from a $203m US tax refund, which helped alleviate some of the financial pressure.

Moving forward, the company has a full film slate for 2022, suggesting the disruptions to movie production are now over. And with customer spending rising by 29% versus pre-pandemic levels, the future seems bright for the Cineworld share price. Or at least it would be if it weren’t for a looming cataclysm (dramatic pause).

The growing risk surrounding Cineworld’s share price

Something I’ve discussed before is the state of this business’s financials, specifically its debt. Despite the solid progress made last year, the pile keeps getting bigger. At the end of 2021, total debt stood at just under $5.2bn. That’s up from $4.7bn in 2020. And when I slap on another $4bn of lease liabilities, $548m of which is due before the end of 2022, the situation only gets worse.

To add more fuel to the fire, these vast financial obligations have pushed the interest bill to $782m from $548.4m. And that’s before the Bank of England started raising interest rates. To top it all off, the company now has to pay $980m in damages to Cineplex after pulling out of a signed acquisition deal when the pandemic began.

Management is contesting the latter expense in court. But even if it succeeds in appealing the decision, without any positive operating cash flows the group’s debt burden will only worsen. And returning to pre-pandemic levels of profitability simply won’t be enough to cover the rising interest expenses.

In my opinion, Cineworld and its share price seem to have all the characteristics of a sinking ship. That’s why I’m personally not interested in adding any shares to my portfolio today.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Abstract bull climbing indicators on stock chart
Investing Articles

Could the Chancellor’s Leeds Reforms trigger a bull market for UK stocks?

More competitive lending and greater interest in shares could help kick start growth for UK businesses. But could it also…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

I think this AI stock could double before Palantir

Palantir stock is up almost 100% this year. As a result, it now sports a market cap of $350bn meaning…

Read more »

Elevated view over city of London skyline
Investing Articles

As the FTSE 100 hits an all-time high, is it time to reconsider the S&P 500?

Christopher Ruane explains why a surging FTSE 100 has not yet made him focus more on the potential of S&P…

Read more »

GSK scientist holding lab syringe
Investing Articles

The FTSE 100 sits at a record high. But some stocks still look dirt cheap!

The usually sluggish FTSE 100 is having a surprisingly good year. But our writer feels there are still potential bargains…

Read more »

Close-up of British bank notes
Investing Articles

With a £20k Stocks and Shares ISA, here are 3 ways an investor could target a £2k annual passive income

Our writer thinks there is more than one way to try and skin a cat when it comes to earning…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 350% in 3 years but my favourite FTSE growth share is still on a low P/E of just 10!

Harvey Jones can't tear his eyes away from this former penny stock turned growth share superpower. But can it carry…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 83% in months, could Micron stock be the next Nvidia?

Chipmaker Micron Technology's stock price has surged by over 80% in just a few months. Could this be a possible…

Read more »

Tesla car at super charger station
US Stock

£1k invested in Tesla stock at the start of the year is currently worth…

Jon Smith reveals the performance of Tesla stock in 2025 and explains why he doesn't believe the move lower is…

Read more »